Fulgent Genetics, Inc. Common Stock
Market Cap
530M
Short interest (May 15)
9.6%
Net Short (Jun 03 ): 0.1%
Borrow Fee
0.27%
↑ 23.4%
Available Shares
1M
↓ 7.0%
Price Chart
Company Overview
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in the laboratory services business and the therapeutic development business. The laboratory services business, which generates key revenue, includes technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue, and Foreign.
Company Info
Market Data
Short Interest
Recent Changes
Quick Actions
Investment Risk
This is not financial advice. All investments carry risk. Do your own research before making investment decisions.